For the quarter ending 2025-09-30, AURX has $1,927,637 in assets. $2,347,243 in debts. $514,797 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 514,797 | 316,354 | ||
| Accounts receivable, net | 652,252 | 320,440 | ||
| Inventory, net | 201,627 | 165,816 | ||
| Prepaid expenses and other current assets | 93,977 | 50,670 | ||
| Total current assets | 1,462,653 | 853,280 | ||
| Property, plant, and equipment, gross | 841,414 | - | ||
| Less accumulated depreciation | 494,392 | - | ||
| Property and equipment, net | 347,022 | 370,170 | ||
| Operating lease right of use assets | 117,962 | 136,035 | ||
| Total assets | 1,927,637 | 1,359,485 | ||
| Accounts payable | 491,659 | 312,884 | ||
| Accrued expenses | 390,892 | 314,554 | ||
| Deferred revenue | 300,000 | 300,000 | ||
| Current portion of operating lease liabilities | 73,935 | 71,517 | ||
| Total current liabilities | 1,256,486 | 998,955 | ||
| Deferred revenue long term | 1,050,000 | 1,125,000 | ||
| Non-current portion of operating lease liabilities | 40,757 | 60,091 | ||
| Total liabilities | 2,347,243 | 2,184,046 | ||
| Common stock 0.0001 par value, 100,000,000 shares authorized, 47,881,121 and 46,816,114 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 4,788 | 4,683 | ||
| Additional paid-in capital | 33,769,288 | 32,826,519 | ||
| Accumulated deficit | -34,193,682 | -33,655,763 | ||
| Total stockholders' equity/(deficit) | -419,606 | -824,561 | ||
| Total liabilities and stockholders' equity/(deficit) | 1,927,637 | 1,359,485 | ||
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)